Liver cancer is one of the most common cancers worldwide. It is also one of the deadliest cancers. Despite advances made in treatment, there is no known cure for the disease yet, hence, prevention is a key factor in reducing mortality. And many liver cancers can be prevented by reducing exposure to known risk factors for this disease. Worldwide, the most significant risk factor for liver cancer is chronic infection with hepatitis B virus (HBV) and hepatitis C virus (HCV). In this episode of Physician’s Weekly Peter Hofland, Ph.D. talks with Andrea Wilson Woods, the President and Founder of Blue Feary, a patient advocacy organization, about liver cancer and about “Love Your Liver!" a 28-day public awareness campaign which the organization is conducting this month.
Also, in this edition of Physician’s Weekly:
- Paul Schmidt spoke with Siva Narayanan, the Chief Executive Officer Avant Health about a recent survey among consumers here in the United States about who would "probably not" or "definitely not" accept the coronavirus vaccine, and
- Rachel Giles, MD, spoke with Graham McMahon, MD, MMSc, President and Chief Executive Officer of the Accreditation Council for Continuing Medical Education (ACCME) about trends in medical education and how physicians can stay up to date with the latest clinical developments. McMahon leads efforts to leverage the power of accredited CME to address national and international healthcare challenges.